Publication:
Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis

No Thumbnail Available

Date

2021-02

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Mendoza, Dexter P., Allen Heeger, Mari Mino-Kenudson, Michael Lanuti, Jo-Anne O. Shepard, Lecia Sequist, and Subba R. Digumarthy. 2021. “Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated With Cystic Airspaces: A Systematic Review and Meta-Analysis.” American Journal of Roentgenology (1976) 216 (2): 318–29.

Research Data

Abstract

Background: Lung cancer with cystic airspaces (LC-CAS) is an uncommon presentation of primary lung malignancy. Due to their rarity and atypical appearance, there can be delays in diagnosis and treatment. Evidence acquisition: We searched for published papers on the clinicopathologic and imaging features of LC-CAS and included studies based on predefined criteria. We extracted the clinicopathologic characteristics of the patients with LC-CAS and computed tomography (CT) imaging features of LC-CAS and performed pooled analysis for reported continuous and categorical data. Evidence synthesis: The analysis included 8 original research studies with combined 341 patients with LC-CAS (weighted mean age: 61.8 years; range: 30-87 years). Majority had stage I disease (134/217, 61.8%). The most common histologies were adenocarcinoma (289/328, 88.1%) and squamous cell carcinoma (30/328, 9.1%). The cysts in LC-CAS commonly had non-uniform (104/114; 91.2%) and thick (83/222; 37.4%) walls, had irregular margins (53/142; 37.3%), and were multilocular (99/272; 36.4%). Most LC-CAS had a nodule or soft tissue component (210/328; 64.0%). Over time, most LC-CAS had development or enlargement of the solid component (61/89, 68.5%), approximately half (43/89, 48.3%) had interval wall thickening, and a minority evolved into completely solid masses or nodules (11/89, 12.4%). The cystic component can increase (36/89, 40.4%), decrease (28/89, 31.5), or remain stable (24/89, 27.0%) in size. Conclusion: Lung cancer should be suspected in cystic lung lesions with associated wall thickening or nodularity, and the index of suspicion should be further raised if wall thickening increases or nodule develops. The cystic component in LC-CAS may enlarge, remain stable, or decrease in size over time; stability or decreased size of the cyst should not be taken as a sign of benignity. These lesions can be indolent and close and long-term follow up with imaging should be considered if these lesions are not biopsied or resected.

Description

Other Available Sources

Keywords

Terms of Use

Metadata Only

Endorsement

Review

Supplemented By

Referenced By

Related Stories